Novo Nordisk (Germany) Analysis

Novo Stock Analysis Notes

The company has Price/Earnings To Growth (PEG) ratio of 2.0. Novo Nordisk AS last dividend was issued on the 24th of March 2023. The entity had 1:2 split on the 18th of September 2023. Novo Nordisk AS, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. NOVO NORDISK is traded on Frankfurt Stock Exchange in Germany. To find out more about Novo Nordisk AS contact Lars Jorgensen at 45 44 44 88 88 or learn more at https://www.novonordisk.com.

Novo Nordisk AS Investment Alerts

Novo Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 303.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Nordisk's market, we take the total number of its shares issued and multiply it by Novo Nordisk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novo Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.43 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.43.

Technical Drivers

As of the 23rd of March, Novo Nordisk secures the Risk Adjusted Performance of (0.11), standard deviation of 3.73, and Mean Deviation of 2.51. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novo Nordisk AS, as well as the relationship between them. Please verify Novo Nordisk AS mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Novo Nordisk AS is priced some-what accurately, providing market reflects its recent price of 70.6 per share.

Novo Nordisk AS Price Movement Analysis

Novo Nordisk Outstanding Bonds

Novo Nordisk Predictive Daily Indicators

Novo Nordisk Forecast Models

Novo Nordisk's time-series forecasting models are one of many Novo Nordisk's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novo Nordisk's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Novo Nordisk prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novo Nordisk. By using and applying Novo Stock analysis, traders can create a robust methodology for identifying Novo entry and exit points for their positions.

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.